|
|
|
Insider
Information: |
Giles Lisa M. |
Relationship: |
Director |
City: |
Chicago |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
35,815 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
35,815 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Durata Therapeutics, Inc. |
DRTX |
Director |
2014-11-17 |
0 |
2013-12-03 |
0 |
Premium* |
|
Genmark Diagnostics, Inc. |
GNMK |
Director |
2021-04-22 |
0 |
2021-04-22 |
0 |
Premium* |
|
Hcw Biologics Inc. |
HCWB |
Director |
2024-02-20 |
35,815 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2015-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,730 |
1,730 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,483 |
8,213 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2016-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,497 |
16,710 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,981 |
23,691 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
17,107 |
40,798 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,937 |
58,735 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
702 |
59,437 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2019-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
528 |
59,965 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
13,825 |
73,790 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,782 |
81,572 |
0 |
- |
|
HCWB |
Hcw Biologics Inc. |
Director |
|
2024-02-20 |
4 |
A |
$1.40 |
$50,001 |
D/D |
35,715 |
35,815 |
0 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-08-06 |
4 |
B |
$8.25 |
$4,125 |
D/D |
500 |
1,500 |
2.31 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2013-12-03 |
4 |
B |
$10.95 |
$10,950 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2015-11-03 |
4 |
B |
$6.60 |
$26,400 |
I/I |
4,000 |
4,500 |
2.1 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2016-08-12 |
4/A |
B |
$9.40 |
$1,664 |
I/I |
177 |
5,500 |
2.02 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2016-08-12 |
4 |
B |
$9.40 |
$7,736 |
I/I |
823 |
5,323 |
2.1 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,500) |
0 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2021-04-22 |
4 |
D |
$24.05 |
$1,961,807 |
D/D |
(81,572) |
0 |
0 |
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2021-04-22 |
4 |
D |
$24.05 |
$132,275 |
I/I |
(5,500) |
0 |
0 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
Director |
|
2012-07-19 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
GNMK |
Genmark Diagnostics, Inc. |
Director |
|
2015-02-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
500 |
|
- |
|
HCWB |
Hcw Biologics Inc. |
Director |
|
2021-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|